Skip to main content
E

ERA CO.,LTD. — Investor Relations & Filings

Ticker · 002641 ISIN · CNE1000019M5 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,651 across all filing types
Latest filing 2020-03-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002641

ERA CO., LTD. is a leading manufacturer specializing in the research, development, and production of plastic piping systems. The company offers a comprehensive range of products, including PVC, PE, PP-R, CPVC, and PE-RT pipes and fittings. These solutions are widely utilized across diverse sectors such as municipal water supply, drainage, electrical conduit, telecommunications, gas distribution, and agricultural irrigation. ERA is recognized for its large-scale production capabilities and commitment to quality standards, maintaining a significant presence in both domestic and international markets. The company focuses on providing integrated piping solutions that emphasize durability, efficiency, and environmental sustainability. Its product portfolio also extends to valves and electrical switches, supporting a broad spectrum of infrastructure and construction requirements.

Recent filings

Filing Released Lang Actions
第四届监事会第十六次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 16th meeting of the 4th Supervisory Board of 永高股份有限公司 (Yonggao Co., Ltd.) held on March 27, 2020. It details the meeting attendance, voting results, and decisions on matters such as related party transactions and use of raised funds for capital increase in subsidiaries. The document does not contain financial statements or detailed financial data but rather reports on the supervisory board's decisions and approvals. It also references other announcements published on March 28, 2020, for more detailed information. The document length is 1775 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of board resolutions and related corporate governance matters, not a full financial report or a management report.
2020-03-27 Chinese
浙商证券股份有限公司关于公司使用募集资金向全资子公司进行增资的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal opinion from a sponsoring securities firm (浙商证券股份有限公司) regarding the use of raised funds by 永高股份有限公司 to increase capital in its wholly-owned subsidiary. It references regulatory approvals, specific fund usage, and compliance with listing rules and supervisory guidelines. The document is focused on the verification and opinion on the use of funds rather than presenting financial statements or results. It is not an annual or interim report, nor an earnings release or management discussion. It is a regulatory compliance-related document concerning capital use and fund management. Given the content and length (2506 characters), it is not a full financial report but a regulatory filing related to capital use verification. Therefore, the best fitting category is Regulatory Filings (RNS).
2020-03-27 Chinese
独立董事对第四届董事会第二十七次会议相关事项事前认可意见
Board/Management Information Classification · 95% confidence The document is a statement from independent directors providing their prior approval opinion on a specific agenda item for a board meeting, specifically regarding anticipated related party transactions for the year 2020. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules, and it is dated March 27, 2020. The content is focused on board-level governance and approval processes rather than financial results, audit, or shareholder voting outcomes. It does not contain financial statements or earnings data, nor is it a report or announcement of a report publication. The document fits best under Board/Management Information (MANG) as it relates to board meeting matters and director opinions on company governance issues.
2020-03-27 Chinese
关于使用募集资金对全资子公司进行增资的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 永高股份有限公司 regarding the use of raised funds (募集资金) to increase capital in its wholly-owned subsidiary. It details the approval by the board and supervisory committee, the amount and source of funds (proceeds from convertible bonds), and confirms compliance with regulatory requirements. The document includes independent director opinions, supervisory board opinions, and sponsor institution verification. It is a formal disclosure about a financing activity involving capital injection into a subsidiary, not a full financial report, earnings release, or management discussion. The document length is about 3,340 characters, which is relatively short and focused on a specific financing update. Therefore, it fits best under Capital/Financing Update (CAP).
2020-03-27 Chinese
关于使用募集资金置换预先投入募投项目自筹资金的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 永高股份有限公司 regarding the use of raised funds (募集资金) to replace self-raised funds previously invested in projects. It details the approval by the board and supervisory committee, the amount of funds raised through convertible bonds, and the specific projects involved. The document includes independent director opinions, supervisory board opinions, and sponsor opinions, as well as references to verification reports by an accounting firm. The document length is about 3500 characters, which is relatively short and primarily serves as an announcement of a financing and fund usage update rather than a full financial report or audit. It does not contain comprehensive financial statements or detailed financial analysis but focuses on the capital/financing update related to the use of raised funds. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2020-03-27 Chinese
独立董事对第四届董事会第二十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various company matters discussed at a board meeting, including approval of foreign exchange forward contracts, related party transactions, futures hedging, and use of raised funds for subsidiary capital increase and project funding. It references compliance with company law, securities regulations, and listing rules, and provides independent opinions on these corporate governance and financial risk management issues. The document is not a full financial report, earnings release, or regulatory filing but rather a formal management/board-related opinion document. It fits best under Board/Management Information (MANG) as it relates to board meeting matters and independent directors' opinions on company decisions.
2020-03-27 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.